<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02020954</url>
  </required_header>
  <id_info>
    <org_study_id>Becker-Heart-Study</org_study_id>
    <nct_id>NCT02020954</nct_id>
  </id_info>
  <brief_title>Prospective Becker-Heart-Study</brief_title>
  <acronym>Becker-HS</acronym>
  <official_title>Prospective Cohort Study of Patients With Mutations in the Dystrophin Gene (X Linked Dilated Cardiomyopathy and Becker Muscular Dystrophy)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karim WAHBI</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut de Myologie, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut de Myologie, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether electrocardiogram, echocardiography,
      cardiac MRI, sera biomarkers can improve early detection of myocardial involvement and
      clinical outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cohort of 100 patients with mutations in the dystrophin gene associated with Becker
      muscular dystrophy and/or dilated cardiomyopathy will be included (patients with Duchenne
      muscular dystrophy are excluded).

      Patients with undergo at baseline the following workups: electrocardiogram, echocardiography,
      cardiac MRI, sera biomarkers measurement.

      At 3 years and 5 years, patients will be investigated according to the same protocol and
      occurrence of cardiac adverse events in the meanwhile will be recorded.

      Statistical analysis will assess correlations between cardiac phenotype and DMD mutations and
      prognostic value of cardiac investigations.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite endpoint: hospitalisation for heart failure, death due to heart failure</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Dilated Cardiomyopathy</condition>
  <condition>Lef Ventricular Dysfunction</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Dystrophinopathy</arm_group_label>
    <description>Patients with mutations in the DMD gene and Becker muscular dystrophy and/or dilated cardiomyopathy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ECG, echocardiography, cardiac MRI, sera biomarkers</intervention_name>
    <arm_group_label>Dystrophinopathy</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with mutations in the DMD gene and Becker muscular dystrophy and/or dilated
        cardiomyopathy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mutation in the DMD gene

          -  Becker muscular dystrophy and/or dilated cardiomyopathy

          -  age&gt;18 years

          -  affiliation to the French medical insurance

        Exclusion Criteria:

          -  Duchenne muscular dystrophy

          -  Any other chronic disease that may be associated with heart disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karim Wahbi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut de Myologie, Cochin Hospital, Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karim Wahbi, MD, PhD</last_name>
    <email>karim.wahbi@cch.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut de Myologie</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nawal Berber, PhD</last_name>
      <email>n.benammar@institut-myologie.org</email>
    </contact>
    <investigator>
      <last_name>Karim Wahbi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2013</study_first_submitted>
  <study_first_submitted_qc>December 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 25, 2013</study_first_posted>
  <last_update_submitted>March 23, 2015</last_update_submitted>
  <last_update_submitted_qc>March 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Institut de Myologie, France</investigator_affiliation>
    <investigator_full_name>Karim WAHBI</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

